Article info

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer
Free
  1. Correspondence to:
 Dr W D Foulkes, Montreal General Hospital/Room L10-120, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada;
 william.foulkes{at}mcgill.ca
View Full Text

Citation

Chappuis PO, Goffin J, Wong N, et al
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

Publication history

  • First published August 1, 2002.
Online issue publication 
August 01, 2002
  •  
    Web-only Tables

    A significant response to neoadjuvant chemotherapy in
    BRCA1/ 2related breast cancer
    PO Chappuis, J Goffin, N Wong, C Perret, P Ghadirian, PN Tonin, WD Foulkes

    Supplementary Table 1 Breast cancer patients carrying a BRCA1/2 germline mutation and treated with neoadjuvant chemotherapy: clinicopathological characteristics and response to treatment
    [View Table]

    Supplementary Table 2 Breast cancer patients who do not carry a BRCA1/2 germline mutation, treated with neoadjuvant chemotherapy: clinico-pathological characteristics and response to treatment
    [View Table]

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.